Seeking Alpha

Trius Therapeutics (TSRX) announces a secondary offering, no details as to the actual size or...

Trius Therapeutics (TSRX) announces a secondary offering, no details as to the actual size or terms of the offering have been disclosed. Citigroup and Leerink Swann are acting as joint book-running managers and Baird is acting as a co-lead manager. Shares -5.5% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|